The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.
暂无分享,去创建一个
Vincent Lebon | Staffan Enocksson | K. Petersen | S. Dufour | D. Befroy | G. Shulman | G. Cline | S. Inzucchi | V. Lebon | Silvio E Inzucchi | Gary W Cline | Gerald I Shulman | Sylvie Dufour | Kitt F Petersen | Adam B. Mayerson | R. Hundal | S. Enocksson | Douglas Befroy | Adam B Mayerson | Ripudaman S Hundal | Adam Mayerson
[1] G. Cooney,et al. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. , 2001, Diabetes.
[2] B. Spiegelman,et al. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. , 1995, Current opinion in genetics & development.
[3] G. Lusk,et al. ANIMAL CALORIMETRY Twenty-Fourth Paper. ANALYSIS OF THE OXIDATION OF MIXTURES OF CARBOHYDRATE AND FAT , 1924 .
[4] P. Scifo,et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.
[5] G. Boden,et al. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. , 1995, The Journal of clinical investigation.
[6] U. Ungerstedt,et al. Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: dialysate glucose concentration is blood-flow-dependent. , 1991, Acta physiologica Scandinavica.
[7] D L Rothman,et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.
[8] A. Keys,et al. DENSITOMETRIC ANALYSIS OF BODY COMPOSITION: REVISION OF SOME QUANTITATIVE ASSUMPTIONS * , 1963, Annals of the New York Academy of Sciences.
[9] S. Lillioja,et al. Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.
[10] J. Aikens,et al. A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.
[11] C. Mantzoros,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Leptin Concentrations in the Polycystic Ovary Syndrome* , 2022 .
[12] F Schick,et al. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: Two lipid compartments in muscle tissue , 1993, Magnetic resonance in medicine.
[13] P. Arner,et al. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. , 1996, Trends in pharmacological sciences.
[14] T. Buchanan,et al. Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus , 1998, Annals of Internal Medicine.
[15] K. Eguchi,et al. Efficacy of troglitazone on body fat distribution in type 2 diabetes. , 2000, Diabetes care.
[16] K. Petersen,et al. Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.
[17] J. Bolinder,et al. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[18] G. Cooney,et al. Peroxisome Proliferator—Activated Receptor (PPAR)-α Activation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats Comparison With PPAR-γ Activation , 2001 .
[19] S. O’Rahilly,et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. , 1997, The Journal of clinical investigation.
[20] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[21] J. Olefsky,et al. Effect of Troglitazone on Leptin Production: Studies In Vitro and in Human Subjects , 1996, Diabetes.
[22] N. Tajima,et al. Effect of troglitazone on body fat distribution in type 2 diabetic patients. , 1999, Diabetes care.
[23] N. Tajima,et al. Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy--a randomized controlled trial. , 2001, Metabolism: clinical and experimental.
[24] D. Rothman,et al. Improvements on an in Vivo automatic shimming method (FASTERMAP) , 1997, Magnetic resonance in medicine.
[25] A. Häkkinen,et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. , 2000, Diabetes.
[26] G. Shulman,et al. On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .
[27] G. Shulman,et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] U. Ungerstedt,et al. Microdialysis in the study of extracellular levels of amino acids in the rat brain. , 1986, Acta physiologica Scandinavica.
[29] J. Hoofnagle,et al. Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes , 2000, Annals of Internal Medicine.
[30] K. Petersen,et al. Mechanism of troglitazone action in type 2 diabetes. , 2000, Diabetes.
[31] N. Sato,et al. Troglitazone Reduces Plasma Leptin Concentration but Increases Hunger in NIDDM Patients , 1998, Diabetes Care.
[32] K. Umesono,et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.
[33] K. Schröder,et al. Role of renal arterial pressure in the regulation of extracellular volume in conscious dogs. , 1992, Clinical science.
[34] R. Hammer,et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy , 1999, Nature.
[35] G. Shulman,et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.
[36] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[37] U. Ungerstedt,et al. The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysis. , 1992, Acta physiologica Scandinavica.
[38] G. Shulman,et al. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. , 1999, Diabetes.
[39] Robert R. Wolfe,et al. Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis , 1992 .
[40] J. Bülow,et al. Assessment of adipose tissue metabolism in man: comparison of Fick and microdialysis techniques. , 1993, Clinical science.
[41] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[42] G. Shulman,et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. , 1998, The New England journal of medicine.
[43] M. Lean,et al. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. , 1999, Diabetes care.
[44] C. Day. Thiazolidinediones: a new class of antidiabetic drugs , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[45] T. Saruta,et al. Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes. , 1999, Metabolism: clinical and experimental.
[46] G. Shulman,et al. Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.
[47] R. Buckingham,et al. Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y , 1997, British journal of pharmacology.
[48] L. DiPietro,et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.
[49] L. Chao,et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. , 2000, The Journal of clinical investigation.
[50] E. Kraegen,et al. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. , 1999, American journal of physiology. Endocrinology and metabolism.